Is Congress About to Reduce Funding for Bioterrorism Vaccines?
In 2004, Congress passed the Project BioShield Act—a ten-year, $5.6 billion fund for purchasing vaccines to use in the event of a bioterrorist attack. But, faced with budget constraints and perceptions of a decreased terrorist threat, Congress is having second thoughts about how it funds the program. Project BioShield established steady, guaranteed funding of $560…